Biogen Inc. buy Royal Bank of Canada
Start price
22.04.25
/
50%
€103.25
Target price
22.04.26
€195.75
Performance (%)
56.26%
End price
23.04.26
€161.34
Summary
This prediction ended on 23.04.26 with a price of €161.34. The BUY prediction by Royal_Bank_of_Canada for Biogen Inc. saw massive gains of 56.26%. Royal_Bank_of_Canada has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 3.881% | 3.881% | 46.526% |
| iShares Core DAX® | -0.843% | 3.002% | 2.841% |
| iShares Nasdaq 100 | 1.510% | 13.493% | 33.438% |
| iShares Nikkei 225® | -0.062% | 11.462% | 41.789% |
| iShares S&P 500 | 0.648% | 8.040% | 23.767% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $221.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten